Purchase Order AG4216P160028
- Not listed
- Oxford Nanopore Technologies Inc. was awarded a $8,450 firm fixed-price purchase order by a Southeast Area civilian federal agency for a Spot On Flow Cell MKI (R9.5) component. The contract was awarded on June 5, 2017, with an ultimate completion date of June 22, 2017, and did not utilize a set-aside designation. Performance of the work was to be completed in Gainesville, Florida. As a leading provider of nanopore-based sequencing technologies, Oxford Nanopore Technologies Inc. supplies...
- Oxford Nanopore Technologies Inc. was awarded a $24.6K firm fixed-price purchase order by the Southeast Area civilian agency on September 27, 2019, for a bulk order of 48 flow cells (FLO-MIN106D R9.4 model). The contract, which is not associated with a set-aside designation, was completed by September 30, 2019, with performance occurring in Stoneville, Mississippi. Flow cells are consumable components essential to Oxford Nanopore's nanopore sequencing platforms, enabling researchers to conduct...
- Oxford Nanopore Technologies Inc. was awarded a $79,026 firm fixed-price purchase order on August 23, 2017, for the delivery of flow cells and sequencing kits to a civilian federal agency in the Southeast Area. The contract, with a completion date of September 1, 2017, was not issued under a set-aside designation. The work will be performed in Gainesville, Florida. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based electronic sequencing...
- Oxford Nanopore Technologies Inc. was awarded a $25.3K firm fixed-price purchase order on August 23, 2017, for SPOTON Flow Cell MKI (R9.5) consumables, with an ultimate completion date of September 30, 2017. The contract, which carries no set-aside designation, will be performed in Cambridge, MA. The funding agency is identified as the Pacific West Area, a civilian federal agency. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based electronic...
- Oxford Nanopore Technologies Inc. was awarded a $47,960 firm fixed-price purchase order by a civilian federal agency (Midwest Area) on December 6, 2019, for genomic sequencing consumables and reagents. The contract, which was set aside for total small business, called for the delivery of MinION flow cells (FLO-MIN 106D R9 and FLO-MIN 110 R10 models) and ligation sequencing kits (SQK-LSK109), with an ultimate completion date of December 20, 2019. The place of performance was Cambridge, MA, and...
- On April 13, 2017, a civilian federal agency's Midwest Area division awarded Oxford Nanopore Technologies Inc. a firm fixed-price purchase order for a MinION DNA sequencer. The contract, valued at $10,109.00, was completed by May 8, 2017, with the place of performance in Cambridge, Massachusetts. No small business set-aside was utilized for this procurement. Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based sequencing systems, supplied this...
- The U.S. government awarded a Purchase Order contract valued at $4,999.00 to Oxford Nanopore Technologies Inc., a biotechnology company specializing in nanopore-based sequencing systems, on February 28, 2017, with completion targeted for March 10, 2017. The contract, titled "Enhanced Minion Starter Pack (2189)," was issued through the Plains Area civilian agency and does not include a set-aside designation. Work will be performed in Cambridge, Massachusetts. Oxford Nanopore...
- This federal contract award is for the procurement of a FLOW CELL, CAT#FLO-MIN 106/7 by the Southeast Area, a civilian agency within the U.S. government. The contract was awarded to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, on August 15, 2018 for a total ceiling value of $116,016.00. The contract is a firm fixed-price purchase order with an ultimate completion date of August 23, 2019. The contract does not have a set-aside designation. Oxford...
- This federal contract award, valued at $17,732.00, was made by the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the provision of various Oxford Nanopore sequencing products, including MinION flow cells, VolTRAX sequencing kits, Flongle flow kits, and flow cell wash kits. These products are to be used with the Oxford Nanopore MinION sequencing device...
- This is a firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $14,475.00 contract is for the delivery of 24 flow cells to support an ongoing research project led by Dr. Chengfei Jiang. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. is an established federal contractor, holding several...
Oxford Nanopore Technologies Inc. was awarded a firm fixed price purchase order valued at $9,480 on March 18, 2016, for a FLO-MAP 103.12 Minion Flow Cell. The contract was funded by a civilian federal agency within the Southeast Area and does not utilize a set-aside designation. Performance is scheduled to conclude by June 30, 2016, with the place of performance in Cambridge, MA. The Minion Flow Cell is a consumable component essential to Oxford Nanopore's portable nanopore sequencing devices, which enable real-time, long-read DNA and RNA analysis for genomic research applications. This award reflects Oxford Nanopore Technologies' established role as a supplier of advanced sequencing technologies to U.S. federal agencies. The company specializes in nanopore-based electronic systems for single-molecule analysis and has supplied genomic sequencing equipment, consumables, and reagents to numerous government agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Defense. The purchase of flow cells, as consumable supplies, supports ongoing research initiatives requiring next-generation sequencing capabilities for applications ranging from infectious disease tracking to biomedical studies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 3/18/16 |